Skip to content

PHARMAMED: what changed

BE 0444.844.572NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€186,710
2024 · €127,432+€59,278
Equity
€439,425
2024 · €402,716+€36,710
Cash
€410,981
2024 · €258,589+€152,393
Balance sheet total
€1.4m
2024 · €1.3m+€120,517

Largest movements

2024 to 2025
Assets
  • Cash +€152,393

    up €152,393 (+58.9%), from €258,589 to €410,981

    mainly Net result for the year (+€186,710) and Depreciation (+€62,317)

  • Receivables within one year -€33,740

    down €33,740 (-6.6%), from €514,902 to €481,162

    of which Other amounts receivable: -€21,191

  • Tangible fixed assets -€27,652

    down €27,652 (-20.1%), from €137,592 to €109,940

    of which Furniture and vehicles: -€26,494

  • Stocks and contracts +€21,253

    up €21,253 (+5.6%), from €380,000 to €401,253

Equity and liabilities
  • Other debts +€49,876

    up €49,876 (+43.3%), from €115,059 to €164,936

  • Trade debts +€47,032

    up €47,032 (+6.8%), from €688,682 to €735,714

  • Profit (loss) carried forward +€36,710

    up €36,710 (+134%), from €27,432 to €64,141

  • Debts after one year -€16,201

    down €16,201 (-55.7%), from €29,070 to €12,869

Income statement
  • Gross operating margin +€123,225

    up €123,225 (+30.1%), from €408,778 to €532,003

  • Staff costs +€54,963

    up €54,963 (+26.9%), from €203,985 to €258,949

  • Other operating charges -€23,361

    down €23,361 (-74.7%), from €31,275 to €7,914

  • Financial income -€21,353

    down €21,353 (-71.4%), from €29,902 to €8,549

  • Depreciation +€11,697

    up €11,697 (+23.1%), from €50,620 to €62,317

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €127,432
Gross operating margin +€123,225
Staff costs -€54,963
Depreciation -€11,697
Write-downs +€6,630
Other operating charges +€23,361
Other operating items +€80
Financial income -€21,353
Financial charges +€3,937
Taxes -€9,941
Result 2025 €186,710
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€358,602
Investment -€35,194
Financing -€171,015
Cash 2024 €258,589
Net result for the year +€186,710
Depreciation +€62,317
Stocks and contracts -€21,253
Receivables within one year +€33,740
Deferred charges and accrued income -€7,735
Trade debts +€47,032
Tax, wage and social debts +€7,914
Other debts +€49,876
Investment in fixed assets (net) -€35,194
Debts after one year -€16,201
Current portion of long-term debt -€4,814
Contributions, distributions and other -€150,000
Cash 2025 €410,981
brings cash intakes cash out
Every line side by side 54 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,326,154 €1,446,671 +€120,517 +9.1%
Fixed assets 21/28 €172,663 €145,539 -€27,124 -15.7%
Intangible fixed assets 21 €29,711 €30,239 +€529 +1.8%
Tangible fixed assets 22/27 €137,592 €109,940 -€27,652 -20.1%
Plant, machinery and equipment 23 €1,961 €1,252 -€709 -36.1%
Furniture and vehicles 24 €131,619 €105,125 -€26,494 -20.1%
Other tangible fixed assets 26 €4,012 €3,563 -€450 -11.2%
Financial fixed assets 28 €5,360 €5,360 = 0.0%
Current assets 29/58 €1,153,491 €1,301,131 +€147,641 +12.8%
Stocks and contracts in progress 3 €380,000 €401,253 +€21,253 +5.6%
Stocks 30/36 €380,000 €401,253 +€21,253 +5.6%
Amounts receivable within one year 40/41 €514,902 €481,162 -€33,740 -6.6%
Trade receivables 40 €475,521 €462,972 -€12,549 -2.6%
Other amounts receivable 41 €39,382 €18,191 -€21,191 -53.8%
Cash at bank and in hand 54/58 €258,589 €410,981 +€152,393 +58.9%
Deferred charges and accrued income 490/1 - €7,735 +€7,735
Total equity and liabilities 10/49 €1,326,154 €1,446,671 +€120,517 +9.1%
Equity 10/15 €402,716 €439,425 +€36,710 +9.1%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €313,284 €313,284 = 0.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Tax-exempt reserves 132 €6,593 €6,593 = 0.0%
Distributable reserves 133 €300,491 €300,491 = 0.0%
Profit (loss) carried forward 14 €27,432 €64,141 +€36,710 +134%
Amounts payable 17/49 €923,438 €1,007,245 +€83,807 +9.1%
Amounts payable after more than one year 17 €29,070 €12,869 -€16,201 -55.7%
Financial debts 170/4 €29,070 €12,869 -€16,201 -55.7%
Amounts payable within one year 42/48 €894,369 €994,377 +€100,008 +11.2%
Current portion of amounts payable after more than one year 42 €21,015 €16,201 -€4,814 -22.9%
Trade debts 44 €688,682 €735,714 +€47,032 +6.8%
Suppliers 440/4 €688,682 €735,714 +€47,032 +6.8%
Taxes, remuneration and social security 45 €69,612 €77,526 +€7,914 +11.4%
Taxes 450/3 €41,990 €54,364 +€12,374 +29.5%
Remuneration and social security 454/9 €27,622 €23,163 -€4,460 -16.1%
Other amounts payable 47/48 €115,059 €164,936 +€49,876 +43.3%
Non-recurring operating income 76A €239 - -€239
Remuneration, social security and pensions 62 €203,985 €258,949 +€54,963 +26.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €50,620 €62,317 +€11,697 +23.1%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €7,864 €1,234 -€6,630 -84.3%
Other operating charges 640/8 €31,275 €7,914 -€23,361 -74.7%
Non-recurring operating charges 66A €80 - -€80
Gross operating margin 9900 €408,778 €532,003 +€123,225 +30.1%
Operating profit (loss) 9901 €114,954 €201,589 +€86,635 +75.4%
Financial income 75/76B €29,902 €8,549 -€21,353 -71.4%
Recurring financial income 75 €29,902 €8,549 -€21,353 -71.4%
Financial charges 65/66B €9,611 €5,674 -€3,937 -41.0%
Recurring financial charges 65 €9,611 €5,674 -€3,937 -41.0%
Profit (loss) for the period before taxes 9903 €135,245 €204,464 +€69,219 +51.2%
Income taxes 67/77 €7,813 €17,754 +€9,941 +127%
Profit (loss) for the period 9904 €127,432 €186,710 +€59,278 +46.5%
Profit (loss) for the period to be appropriated 9905 €127,432 €186,710 +€59,278 +46.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€605,300 to €765,583

Midpoint €672,084 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €409,186
Capitalised earnings €801,414 to €1.1m
Indication €605,300 to €765,583

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€439,425
Intangible fixed assets (21)
-€30,239
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€409,186

Capitalised earnings

net result for the year (9904)
2025
€186,710
2024
€127,432
excluding non-recurring income and charges
€127,273
2023
€35,614
excluding non-recurring income and charges
€22,613
2022
€141,056
excluding non-recurring income and charges
€138,556
2020
€1,133,269
Average result, excluding non-recurring income and charges
€112,198
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€801,414 / €934,983 / €1.1m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 13 November 2026 via checked.be.